DGEN Stock Overview
Provides drug discovery tools and services to the biopharmaceutical industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Deltagen Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 9,900.00% |
| 5 Year Change | 9,900.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| DGEN | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | -0.2% |
| 1Y | n/a | -1.6% | 25.8% |
Return vs Industry: Insufficient data to determine how DGEN performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how DGEN performed against the US Market.
Price Volatility
| DGEN volatility | |
|---|---|
| DGEN Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 9.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DGEN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine DGEN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Robert Driscoll | www.deltagen.com |
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases.
Deltagen Inc. Fundamentals Summary
| DGEN fundamental statistics | |
|---|---|
| Market cap | US$3.26k |
| Earnings (TTM) | -US$46.00k |
| Revenue (TTM) | US$770.00k |
0.0x
P/S Ratio0.0x
P/E RatioIs DGEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGEN income statement (TTM) | |
|---|---|
| Revenue | US$770.00k |
| Cost of Revenue | US$4.00k |
| Gross Profit | US$766.00k |
| Other Expenses | US$812.00k |
| Earnings | -US$46.00k |
Last Reported Earnings
Dec 31, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DGEN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 05:16 |
| End of Day Share Price | 2024/12/10 00:00 |
| Earnings | 2015/12/31 |
| Annual Earnings | 2015/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Deltagen Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|